Temps partiel de thromboplastine : Questions médicales fréquentes
Nom anglais: Partial Thromboplastin Time
Descriptor UI:D010314
Tree Number:G09.188.660
Termes MeSH sélectionnés :
Single-Cell Gene Expression Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Temps partiel de thromboplastine : Questions médicales les plus fréquentes",
"headline": "Temps partiel de thromboplastine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Temps partiel de thromboplastine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-19",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Temps partiel de thromboplastine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiogiques du sang",
"url": "https://questionsmedicales.fr/mesh/D001790",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiogiques du sang",
"code": {
"@type": "MedicalCode",
"code": "D001790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Temps partiel de thromboplastine",
"alternateName": "Partial Thromboplastin Time",
"code": {
"@type": "MedicalCode",
"code": "D010314",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert C Gosselin",
"url": "https://questionsmedicales.fr/author/Robert%20C%20Gosselin",
"affiliation": {
"@type": "Organization",
"name": "Davis Health System, Hemostasis and Thrombosis Center, University of California, Sacramento, California."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Dorothy M Adcock",
"url": "https://questionsmedicales.fr/author/Dorothy%20M%20Adcock",
"affiliation": {
"@type": "Organization",
"name": "Laboratory Corporation of America, Burlington, North Carolina."
}
},
{
"@type": "Person",
"name": "Gary W Moore",
"url": "https://questionsmedicales.fr/author/Gary%20W%20Moore",
"affiliation": {
"@type": "Organization",
"name": "Specialist Haemostasis Unit, Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."
}
},
{
"@type": "Person",
"name": "Wayne L Chandler",
"url": "https://questionsmedicales.fr/author/Wayne%20L%20Chandler",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, University of Washington, Seattle."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis.",
"datePublished": "2024-02-07",
"url": "https://questionsmedicales.fr/article/38326561",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41380-024-02452-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical assessment of TGFB1 and HP Relative Gene Expression in the Peripheral Blood of Prostate Cancer Patients.",
"datePublished": "2024-02-01",
"url": "https://questionsmedicales.fr/article/38415559",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2024.25.2.709"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bisphenol F affects neurodevelopmental gene expression, mushroom body development and behavior in Drosophila melanogaster.",
"datePublished": "2024-01-30",
"url": "https://questionsmedicales.fr/article/38301979",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ntt.2024.107331"
}
},
{
"@type": "ScholarlyArticle",
"name": "Subgenome evolutionary dynamics in allotetraploid ferns: insights from the gene expression patterns in the allotetraploid species",
"datePublished": "2024-01-09",
"url": "https://questionsmedicales.fr/article/38264021",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpls.2023.1286320"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation Between DCAMKL-1 Protein Expression and K-ras Gene Mutation in Colorectal Cancer.",
"datePublished": "2024-01-05",
"url": "https://questionsmedicales.fr/article/38196736",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/CMAR.S440845"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiogiques du sang",
"item": "https://questionsmedicales.fr/mesh/D001790"
},
{
"@type": "ListItem",
"position": 4,
"name": "Temps partiel de thromboplastine",
"item": "https://questionsmedicales.fr/mesh/D010314"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Temps partiel de thromboplastine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Temps partiel de thromboplastine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Temps partiel de thromboplastine",
"description": "Quel est l'objectif du test TPT ?\nQuand le TPT est-il prescrit ?\nComment se déroule le test TPT ?\nQuels résultats indiquent un TPT prolongé ?\nLe TPT est-il lié à d'autres tests ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Temps partiel de thromboplastine",
"description": "Quels symptômes peuvent indiquer un problème de coagulation ?\nComment reconnaître une hémorragie interne ?\nLes symptômes varient-ils selon l'âge ?\nLes saignements de nez sont-ils un signe de problème de coagulation ?\nLes femmes enceintes doivent-elles surveiller leur TPT ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Temps partiel de thromboplastine",
"description": "Comment prévenir les troubles de la coagulation ?\nLes vaccinations influencent-elles la coagulation ?\nLe suivi médical est-il essentiel ?\nLes exercices physiques aident-ils à la coagulation ?\nFaut-il éviter certains médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Temps partiel de thromboplastine",
"description": "Comment traiter un TPT prolongé ?\nLes anticoagulants affectent-ils le TPT ?\nDes suppléments peuvent-ils aider ?\nLe traitement est-il différent pour les enfants ?\nLes changements alimentaires influencent-ils le TPT ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Temps partiel de thromboplastine",
"description": "Quelles sont les complications d'un TPT prolongé ?\nUn TPT anormal peut-il entraîner des AVC ?\nLes complications varient-elles selon l'âge ?\nComment gérer les complications liées au TPT ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Temps partiel de thromboplastine",
"description": "Quels sont les facteurs de risque de troubles de la coagulation ?\nLe tabagisme influence-t-il la coagulation ?\nL'obésité est-elle un facteur de risque ?\nLes maladies chroniques influencent-elles le TPT ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D010314?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quel est l'objectif du test TPT ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer la capacité de coagulation du sang et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quand le TPT est-il prescrit ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lors de l'évaluation des troubles de la coagulation ou avant une chirurgie."
}
},
{
"@type": "Question",
"name": "Comment se déroule le test TPT ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon de sang est prélevé et mélangé avec des réactifs pour mesurer le temps de coagulation."
}
},
{
"@type": "Question",
"name": "Quels résultats indiquent un TPT prolongé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un TPT prolongé peut indiquer des troubles hémorragiques ou une carence en facteurs de coagulation."
}
},
{
"@type": "Question",
"name": "Le TPT est-il lié à d'autres tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent associé à l'INR et au temps de prothrombine pour une évaluation complète."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de coagulation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements spontanés."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des douleurs abdominales, des vomissements de sang ou des selles noires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent présenter des symptômes différents."
}
},
{
"@type": "Question",
"name": "Les saignements de nez sont-ils un signe de problème de coagulation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements de nez fréquents peuvent indiquer un trouble de la coagulation."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles surveiller leur TPT ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des modifications de la coagulation peuvent survenir pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la coagulation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, éviter les blessures et suivre les conseils médicaux."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles la coagulation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent affecter la coagulation, il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il essentiel ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour les personnes à risque de troubles de la coagulation."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à la coagulation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut améliorer la circulation sanguine et la coagulation."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains médicaments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec la coagulation, consultez un médecin."
}
},
{
"@type": "Question",
"name": "Comment traiter un TPT prolongé ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, pouvant inclure des transfusions ou des médicaments."
}
},
{
"@type": "Question",
"name": "Les anticoagulants affectent-ils le TPT ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants comme l'héparine peuvent prolonger le TPT."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de vitamine K peuvent être nécessaires en cas de carence."
}
},
{
"@type": "Question",
"name": "Le traitement est-il différent pour les enfants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dosages et les médicaments peuvent varier selon l'âge et le poids."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires influencent-ils le TPT ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en vitamine K peut améliorer la coagulation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'un TPT prolongé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des saignements graves, des hématomes ou des thromboses."
}
},
{
"@type": "Question",
"name": "Un TPT anormal peut-il entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la coagulation peuvent augmenter le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'âge ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent être plus graves chez les personnes âgées ou les enfants."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au TPT ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion rapide et appropriée des saignements et des traitements médicaux est essentielle."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un suivi médical régulier et des traitements appropriés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de troubles de la coagulation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, certaines maladies et l'utilisation de médicaments anticoagulants."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la coagulation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut affecter la coagulation et augmenter le risque de thrombose."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité augmente le risque de troubles de la coagulation et de complications associées."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le TPT ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies cardiaques peuvent affecter le TPT."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles de la coagulation augmente avec l'âge."
}
}
]
}
]
}
In multiple sclerosis (MS), a non-random and clinically relevant pattern of gray matter (GM) volume loss has been described. Whether differences in regional gene expression might underlay distinctive ...
This study aimed to assess the relative gene expression level of transforming growth factor-β1 (TGFB1) and haptoglobin (HP) in the peripheral blood of prostate cancer (PCa) patients and evaluate their...
A total of 125 participants were enrolled in the present study. Among them, 75 PCa patients, 25 benign prostatic hyperplasia (BPH) patients, and 25 healthy volunteers served as the control group. The ...
TGFB1 was significantly over-expressed, whereas HP was significantly downregulated in the peripheral blood of PCa patients compared to BPH and control groups (p-value ranges from 0.034 to <0.001). Mor...
TGFB1 and HP relative expression have moderate diagnostic efficacy in discriminating patients with PCa from BPH and healthy subjects. Furthermore, over-expression of TGFB1 may contribute to the pathog...
Bisphenol F (BPF) is a potential neurotoxicant used as a replacement for bisphenol A (BPA) in polycarbonate plastics and epoxy resins. We investigated the neurodevelopmental impacts of BPF exposure us...
Allopolyploidization often leads to disruptive conflicts among more than two sets of subgenomes, leading to genomic modifications and changes in gene expression. Although the evolutionary trajectories...
To investigate the correlation between doublecortin and CaM kinase-like-1 (DCAMKL-1) protein expression, K-ras gene mutation, and their impact on patient prognosis in colorectal cancer (CRC)....
Immunohistochemistry was used to detect the expression of DCAMKL-1 protein in 60 cases of colorectal adenoma, 82 cases of CRC (including 65 cases of lymph node metastasis) and paraffin-embedded paraca...
The mutation rate of the K-ras gene in 82 cases of CRC was 48.8% (40/82). The positivity rate for the presence of DCAMKL-1 protein in CRC was 70.7% (58/82), significantly higher than that for colorect...
In this study, a potential positive correlation between K-ras gene mutation and DCAMKL-1 protein expression was identified in CRC tissues. The assessment of K-ras gene mutation status and DCAMKL-1 pro...
Post-acute sequelae of COVID-19 (PASC) is a persistent complication of severe acute respiratory syndrome coronavirus 2 infection that includes symptoms, such as fatigue, cognitive impairment, and resp...
Heat shock transcription factors (HSFs) are crucial for regulating plant responses to heat and various stresses, as well as for maintaining normal cellular functions and plant development. HSFA9 and H...
Type 2 diabetes (T2DM) is a polygenic metabolic disorder that accelerates brain aging and harms cognitive function. The underlying mechanism of T2DM-related brain functional changes has not been clari...
Resting-fMRI data were obtained from 99 T2DM and 109 healthy controls (HCs). Resting-state functional connectivity networks (RSNs) were separated using the Independent Component Analysis (ICA) method,...
The T2DM patients showed significantly increased FC in the left middle occipital gyrus (MOG) of the precuneus network (PCUN) and the right MOG / right precuneus of the dorsal attention network (DAN). ...
This study linked FC and molecular alterations related to T2DM and suggested that the T2DM-related brain FC changes may have a genetic basis. This study hoped to provide a unique perspective to unders...